Loading...

GSK plc

GLAXF•PNK
Healthcare
Drug Manufacturers - General
$26.87
$-0.34(-1.26%)
U.S. Market opens in NaNh NaNm

GSK plc (GLAXF) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap105.4B
P/E Ratio13.71
EPS (TTM)$1.87
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$29.00
3 Months$32.66
1 Year Target$26.76

GLAXF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GSK plc (GLAXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 37.00, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.76.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.71 and a market capitalization of 105.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.26%
5-Day Change
-1.25%
1-Month Change
-1.40%
3-Month Change
7.52%
6-Month Change
28.13%
Year-to-Date (YTD) Change
9.22%
1-Year Change
45.63%
3-Year Change
51.80%
5-Year Change
13.95%
All-Time (Max) Change
6.41%

Contact Information

https://www.gsk.com
44 20 8047 5000
980 Great West Road, Brentford, NaN, TW8 9GS

Company Facts

68,629 Employees
IPO DateJan 5, 2010
CountryGB
Actively Trading

Frequently Asked Questions